Arts Optical International Holdings Ltd (1120) Fair Value & Analysis

Healthcare · HK · Market cap HK$282M (≈ $36.0M) · ISIN BMG0505B1081

What is Arts Optical International Holdings Ltd really worth?

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

What matters now

• The large discount to fair value meets weak quality (43/100). That raises the risk this is a value trap rather than a bargain.
• The price is below even our cautious bear case (HK$0.8800). The market is more pessimistic than our downside scenario.
• The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Price vs Fair Value (5 years)

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range HK$0.4942 – HK$1.77 · fair‑value band HK$0.8800 – HK$1.37 · the HK$0.6000 price screens below the HK$0.9500 fair value. Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Arts Optical International Holdings Ltd (1120) currently trades at HK$0.6000, while our model-based Fair Value estimate is HK$0.9500, implying the stock looks roughly 36.8% undervalued today. The Quality Score stands at 43/100 (below-average quality), in the Healthcare sector. Bull case: the Multiples group reads highest at a median of HK$1.18 per share, and 10 of the 13 models we run sit above the HK$0.6000 price. Bear case: the Earnings-Based group reads lowest at HK$0.5200, and 3 of the 13 models stay below the price. Evidence for this calculation is low.

Over the trailing twelve months, Arts Optical International Holdings Ltd generated revenue of HK$1.3B at a net margin of 1.6%. Revenue grew 9.3% year over year. It earns a return on equity of 5.2%. Net debt stands at HK$225M. Fundamentals as of Aug 13, 2026

Our scenario range runs from HK$0.8800 (bear case) to HK$1.37 (bull case); at HK$0.6000, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 53% below its 52-week high, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at −46% fair-value upside, at 58%, 1120 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.

Widest divergence: Multiples (HK$1.18) versus Earnings-Based (HK$0.5200). Highest evidence: Residual Income (76).

Key figures & financial health

Quality Score breakdown

About the company

Arts Optical International Holdings Limited, an investment holding company, manufactures and trades in prescription frames and sunglasses in Europe, the United States, Asia, and internationally. It manufactures optical lens. The company also engages in property holding and system development activities.

Full company description

Arts Optical International Holdings Limited, an investment holding company, manufactures and trades in prescription frames and sunglasses in Europe, the United States, Asia, and internationally. It manufactures optical lens. The company also engages in property holding and system development activities. It sells its products under the CEO-V, CV by CEO.V, Dakota Smith, MINIBOXX, PAULO PILIPE, RetroCraft, and AustSports brands. The company was incorporated in 1996 and is headquartered in Kwun Tong, Hong Kong.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Arts Optical International Holdings Ltd reported revenue of HK$1.3B in FY2025 versus HK$1.2B in FY2021, a compound +3.7%/yr. Reported net income was HK$20.7M in FY2025, compounding +0.0%/yr from FY2021.

Watch 1120: get an alert when its fair value changes →

Peer Group

Medical Instruments & Supplies · 194 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Valuation Multiples vs Medical Instruments & Supplies median · lower = cheaper

Strength profile in five axes (Snowflake)

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

Discover tools

Frequently asked questions